Gilead Sciences increased the U.S. prices of its top six antiviral drugs that treat HIV by 4.9 percent, according to financial and investment news site Barron's.

Ohio Attorney General Dave Yost is suing pharmacy benefit manager OptumRx to recoup $16 million in alleged overcharges, according to The Columbus Dispatch.

Pharmacy school teaches students the ins and outs of medicine, but far less about how to be an effective pharmacy leader.

While the amount of opioids prescribed per person decreased between 2006 and 2017, the average duration per opioid prescription increased, according to a new study published in JAMA.

Legacy Pharmaceuticals recalled 43 lots of losartan March 15, becoming the latest drugmaker to recall the blood pressure medication due to the detection of a potentially carcinogenic impurity.

A federal judge dismissed a lawsuit filed by six pharmacies that claimed Express Scripts violated health privacy laws and poached customers, according to the St. Louis Post-Dispatch.

Here are 10 hospitals and health systems that posted job listings seeking pharmacy leadership talent in the last week.

Becker's Hospital Review has reported the following six drug or biotech company layoffs in the last two months. They are listed below, beginning with the most recent.

A proposed bill in New Jersey would ban insurers and pharmacy benefit managers from charging a higher copay than the cash price of a medication, according to New Jersey 101.5, a local radio station.

Two co-pharmacy owners were sentenced to 10 years in prison each for creating a bogus pharmacy to obtain and distribute OxyContin and other prescription narcotics to black-market customers, according to NBC Los Angeles.

Merck, the sole supplier of a critical bladder cancer drug, is restricting shipments of the treatment as demand outpaces supply.

A California jury ordered Johnson & Johnson to pay $29 million to a woman who alleged that asbestos in the company's talc-based baby powder caused her fatal cancer, according to Bloomberg.

Oral forms of medications include inactive ingredients to help stabilize the drug or aid in its absorption. While these components are usually harmless, nearly all of these pills contain some ingredients that can cause allergic reactions, a new study published in Science Translational Medicine found.

The chief executive of Novartis' generic drug business Sandoz abruptly stepped down, according to Reuters.

CMS updated its drug spending dashboards with pricing and spending data from 2017 to help increase transparency in healthcare and provide incentives to lower list prices.

Deerfield Management, a healthcare hedge fund, has invested $100 million in a new research and development partnership with Cambridge, Mass.-based Harvard University, according to The Boston Globe.

Purdue Pharma's CEO said a bankruptcy filing is on the table as lawsuits alleging the drugmaker fueled the nation's opioid crisis pile up, according to The Washington Post.

Entry of generic drugs into the market should cause prices to drop. However, the generic industry has recently taken a page from the brand-name industry, engaging in price gouging and making it increasingly difficult to obtain critical medications, Marc Harrison, MD, the CEO of Salt Lake Intermountain Healthcare, wrote in an opinion piece published by STAT.

As costs continue to mount from opioid litigation, Insys Therapeutics faces the risk of going out of business, according to Bloomberg.

Several drugmakers and pharmacy chains are hard at work responding to the hundreds of lawsuits accusing them of fueling the deadly opioid epidemic in the U.S. While billions of dollars are at stake for these companies if they are found liable, their reputations are now on the line — even before any judgements are rendered, according to NPR.